TKI Plus Checkpoint Inhibitor Without Chemotherapy Shows Promise as Initial Option in Advanced NSCLC

Co-mutations in DNA Damage-Response Pathways May Predict Effectiveness of Checkpoint Inhibitors in NSCLC

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

Deeper Dive: A Plethora of Prediction Models

Study Provides Insights That May Inform Prevention, Management of Mesothelioma

IASLC Releases Position Statement on Air Pollution on Earth Day

IASLC Responds to Call for Evidence

Researcher Reveals How Air Pollution May Cause Lung Cancer